Research Paper Volume 16, Issue 13 pp 10813—10831
An immune biomarker associated with EMT serves as a predictor for prognosis and drug response in bladder cancer
Figure 2. Comprehensive analysis of model reliability and gene expression. (A) Kaplan-Meier curves for overall survival in the TCGA-BLCA cohort for the low-risk and high-risk groups. (B) Time-dependent ROC analysis curves for 1-, 3-, and 5-year OS characteristics in the TCGA dataset. (C) Expression of WDHD1 in BLCA and paracancerous tissues (D) WDHD1 expression and clinicopathologic features.